Chuanchao He

583 total citations
21 papers, 411 citations indexed

About

Chuanchao He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chuanchao He has authored 21 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Chuanchao He's work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Chuanchao He is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Epigenetics and DNA Methylation (4 papers) and RNA modifications and cancer (4 papers). Chuanchao He collaborates with scholars based in China and United States. Chuanchao He's co-authors include Jianlong Zhang, Zhiyu Xiao, Zhenyu Zhou, Kai Mao, Yunjie Zeng, Kang Xu, Zhiyu Xiao, Jie Wang, Jie Wang and Junyao Xu and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Advanced Science.

In The Last Decade

Chuanchao He

20 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanchao He China 12 295 166 71 58 50 21 411
Wenxuan Xie China 10 231 0.8× 182 1.1× 85 1.2× 50 0.9× 91 1.8× 22 367
Liguang Yang China 8 218 0.7× 111 0.7× 47 0.7× 48 0.8× 68 1.4× 14 324
Andrew Harrington United States 4 190 0.6× 128 0.8× 54 0.8× 133 2.3× 61 1.2× 4 353
Xiaoyong Cai China 10 223 0.8× 236 1.4× 54 0.8× 32 0.6× 72 1.4× 25 344
Heping Kan China 12 290 1.0× 221 1.3× 89 1.3× 18 0.3× 72 1.4× 18 425
Yorihide Okuda Japan 9 295 1.0× 68 0.4× 55 0.8× 80 1.4× 30 0.6× 16 391
Thi Bich Uyen Le Singapore 9 268 0.9× 64 0.4× 63 0.9× 43 0.7× 27 0.5× 11 336
Bensong Duan China 13 265 0.9× 209 1.3× 47 0.7× 17 0.3× 48 1.0× 27 363
Keiji Nishibeppu Japan 10 224 0.8× 186 1.1× 94 1.3× 36 0.6× 122 2.4× 51 424

Countries citing papers authored by Chuanchao He

Since Specialization
Citations

This map shows the geographic impact of Chuanchao He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanchao He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanchao He more than expected).

Fields of papers citing papers by Chuanchao He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanchao He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanchao He. The network helps show where Chuanchao He may publish in the future.

Co-authorship network of co-authors of Chuanchao He

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanchao He. A scholar is included among the top collaborators of Chuanchao He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanchao He. Chuanchao He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yongcong, Kai Wen, Chuanchao He, et al.. (2025). m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism. Advanced Science. 12(41). e03851–e03851.
2.
Zhou, Zhenyu, Zheng Chen, Shiyu Meng, et al.. (2024). SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression. Cancer Science. 115(5). 1587–1601. 7 indexed citations
3.
Shi, Juanyi, Kai Wen, Chuanchao He, et al.. (2024). Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma. Clinical & Translational Oncology. 26(9). 2181–2197. 1 indexed citations
4.
Liu, Haohan, Yongcong Yan, Jianhong Lin, et al.. (2022). Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular Therapy — Nucleic Acids. 29. 788–802. 16 indexed citations
5.
Liu, Qinghua, Juanyi Shi, Zhenyu Zhou, et al.. (2022). Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. Journal of Gastrointestinal Oncology. 13(2). 833–846. 5 indexed citations
6.
Lin, Jianhong, Yongcong Yan, Shiyu Meng, et al.. (2022). INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 13–13. 12 indexed citations
7.
Liu, Haohan, Yongcong Yan, Jianhong Lin, et al.. (2021). Circular RNA circSFMBT2 Downregulation by HBx Promotes Hepatocellular Carcinoma Metastasis Via the miR-665/TIMP3 Axis. SSRN Electronic Journal. 1 indexed citations
8.
Yan, Yongcong, Pinbo Huang, Kai Mao, et al.. (2020). Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene. 40(1). 28–45. 30 indexed citations
9.
Liu, Haohan, Yongcong Yan, Ruibing Chen, et al.. (2020). Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma. Cancer Cell International. 20(1). 140–140. 14 indexed citations
10.
Liao, Jing, Jinzhu Li, Zhiyu Xiao, et al.. (2019). Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma. Hepatology International. 14(1). 80–95. 21 indexed citations
11.
Chen, Zheng, Wei Yu, Qiming Zhou, et al.. (2019). A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways. Molecular Therapy — Nucleic Acids. 16. 707–720. 47 indexed citations
12.
Zhou, Zhenyu, Hai Jiang, Kangsheng Tu, et al.. (2019). ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 18–18. 35 indexed citations
13.
Zhu, Jie, Hai Jiang, Chuanchao He, et al.. (2017). Surgical Resection and Prognostic Analysis of 142 Cases of Hilar Cholangiocarcinoma. Indian Journal of Surgery. 80(4). 309–317. 4 indexed citations
14.
Wang, Jie, Chuanchao He, Zhenyu Zhou, & Zhiyu Xiao. (2017). Treatment strategy for huge hepatocellular carcinoma with intrahepatic metastasis and macrovascular invasion: a case report and literature review. Journal of Cancer Research and Therapeutics. 14(12). 1233–1233. 8 indexed citations
15.
He, Chuanchao, Zhenyu Zhou, Hai Jiang, et al.. (2016). Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence. Journal of Cancer. 8(1). 39–47. 17 indexed citations
16.
Zhou, Zhenyu, Chuanchao He, & Jie Wang. (2015). Regulation mechanism of Fbxw7-related signaling pathways (Review). Oncology Reports. 34(5). 2215–2224. 24 indexed citations
17.
Mao, Kai, Jianlong Zhang, Chuanchao He, et al.. (2014). Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib. Cancer Letters. 352(2). 245–252. 63 indexed citations
18.
He, Chuanchao, Junyao Xu, Jianlong Zhang, et al.. (2012). High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma. Human Pathology. 43(9). 1425–1435. 88 indexed citations
19.
Xu, Junyao, Chuanchao He, Jianlong Zhang, & Jie Wang. (2012). Association of high histone H3K4 trimethylation level and prognosis of patients with low-TNM-stage hepatocellular carcinoma.. Journal of Clinical Oncology. 30(4_suppl). 171–171. 1 indexed citations
20.
Zhang, Jianlong, Zhiyu Xiao, Gang Wu, et al.. (2011). Clinical significance of PTEN and B7-H1 expressions in pancreatic carcinoma. Zhonghua shiyan waike zazhi. 28(5). 723–726. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenxuan Xie Breakdown of academic impact, for papers by Liguang Yang Breakdown of academic impact, for papers by Andrew Harrington Breakdown of academic impact, for papers by Xiaoyong Cai Breakdown of academic impact, for papers by Heping Kan Breakdown of academic impact, for papers by Yorihide Okuda Breakdown of academic impact, for papers by Thi Bich Uyen Le Breakdown of academic impact, for papers by Bensong Duan Breakdown of academic impact, for papers by Keiji Nishibeppu
Rankless by CCL
2026